Cargando…

Importance of Variables in Nonalcoholic Fatty Liver Disease Patients

Detalles Bibliográficos
Autores principales:	Garg, Vivek Kumar, Goel, Neelam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085956/ https://www.ncbi.nlm.nih.gov/pubmed/30148110 http://dx.doi.org/10.4103/ijem.IJEM_120_18

Ejemplares similares

The Importance of Visceral Adipose Tissue Detected by Imaging Methods to Assess Nonalcoholic Fatty Liver Disease Properly
por: Ozcelik, Fatih, et al.
Publicado: (2021)

Letter regarding “Risk factors in nonalcoholic fatty liver disease”
por: Pratap, Abhijit, et al.
Publicado: (2023)

Intestinal virome: An important research direction for alcoholic and nonalcoholic liver diseases
por: Li, Yan, et al.
Publicado: (2022)

Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Li, Xia, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease: Role of Medical Colleges in its Prevention and Control
por: Nath, Bhola, et al.
Publicado: (2022)

Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”
por: Bibbò, Stefano, et al.
Publicado: (2018)

Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood
por: Di Sessa, Anna, et al.
Publicado: (2021)

Comments to Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Guan, Yong-Song
Publicado: (2014)

The transcontinental variability of nonalcoholic fatty liver disease
por: Oliveira, Claudia P., et al.
Publicado: (2020)

No Association Between Nonalcoholic Fatty Liver Disease and Severe COVID-19? Something We Might Ignore
por: Gao, Hui, et al.
Publicado: (2022)

Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
por: Yu, Jung Hwan
Publicado: (2020)

COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study
por: Yoo, Hae Won, et al.
Publicado: (2022)

Fructoholism in adults: The importance of personalised care in metabolic dysfunction-associated fatty liver disease
por: Salavrakos, Mélissa, et al.
Publicado: (2021)

Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Liu, Yuanbin, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
por: Lee, Seung Min, et al.
Publicado: (2023)

Nonalcoholic steatohepatitis and hepatocellular carcinoma: Beyond the boundaries of the liver
por: Gupta, Tarana
Publicado: (2022)

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease
por: Kim, Mi Na, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease and Abdominal Fat Accumulation According to Vitamin D Status in Patients with Type 2 Diabetes (J Obes Metab Syndr 2018;27:53–60)
por: Hwang, Juchul, et al.
Publicado: (2018)

Hepatic inflammation: an important target for biomarker development in nonalcoholic fatty liver disease
por: Khan, Hiba, et al.
Publicado: (2023)

Increased Risk of Nonalcoholic Fatty Liver Disease in Individuals with High Weight Variability
por: Jung, Inha, et al.
Publicado: (2021)

Acute Fatty Liver of Pregnancy
por: Dey, Madhusudan, et al.
Publicado: (2012)

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease
por: Kumar, Mavidi Sunil, et al.
Publicado: (2016)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

Increasing nonalcoholic fatty liver disease–related mortality rates in the United States from 1999 to 2022
por: Ilyas, Fariha, et al.
Publicado: (2023)

Comments on “The Effects of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease”
por: Cheraghpour, Makan, et al.
Publicado: (2016)

Clinically important alterations in pharmacogene expression in histologically severe nonalcoholic fatty liver disease
por: Powell, Nicholas R., et al.
Publicado: (2023)

Dietary recommendations for patients with nonalcoholic fatty liver disease
por: Kargulewicz, Angelika, et al.
Publicado: (2014)

Referral Patterns for Patients with Nonalcoholic Fatty Liver Disease
por: Rashu, Elias Badal, et al.
Publicado: (2021)

Multiparametric MRI in Patients With Nonalcoholic Fatty Liver Disease
por: Schaapman, Jelte J., et al.
Publicado: (2020)

Cardiac abnormalities in patients with nonalcoholic fatty liver disease
por: Mota, Adriana Hendler, et al.
Publicado: (2022)

The role of hepatic macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Cha, Ji-Young, et al.
Publicado: (2018)

Nonalcoholic steatofibrosis independently predicts mortality in nonalcoholic fatty liver disease
por: Younossi, Zobair M., et al.
Publicado: (2017)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_spvqhfbijcplqlv7pd58lh3j9j